The filing of a class action lawsuit against Edwards Lifesciences is likely to create uncertainty among investors, potentially leading to a decline in stock price as the market reacts to the legal risks and potential financial liabilities. The deadline for joining the lawsuit suggests ongoing legal proceedings, which can further impact investor sentiment.